Desktop | 55/100 | ❗ |
Mobile | 60/100 | ❗ |
Field | Data | Result |
---|---|---|
Page Size | 73 KB | ✔ |
Compression | 12 KB (-83.7%) | ✔ |
Text/Html Ratio | 5552 / 74645 (bytes) = 7.44% | ❗ |
Load Time | 1.68 second | ✘ |
Mobile Ready | 0/100 | ✘ |
In-Page Links | 57 | ✔ |
Doc Type | HTML 5 | ✔ |
Encoding | UTF-8 | ✔ |
Declared Language | EN-US | ✔ |
Preferred Domain | Yes | ✔ |
Robots.txt | No | ✘ |
Url Rewrite | No | ✔ |
Underscores in url | No | ✔ | Images Without ALT | 40 / 41 | ✘ |
Embedded Objects (Desktop) | No | ✔ |
Embedded Objects (Mobile) | Yes | ✘ |
Iframe | Yes | ✘ |
Custom 404 page | Yes | ✔ |
Email Privacy | No | ✘ |
Gsafe browsing | Yes | ✔ |
Analytics | No | ✘ |
W3C Validity | No | ✘ |
Keywords | Freq | Title | Desc | <H> |
---|---|---|---|---|
rare | 13 | ✘ | ✔ | ✘ |
corporate | 9 | ✘ | ✘ | ✘ |
canbridge | 8 | ✔ | ✔ | ✘ |
gene | 8 | ✘ | ✘ | ✘ |
phase | 7 | ✘ | ✘ | ✘ |
therapy | 6 | ✘ | ✘ | ✘ |
financial | 5 | ✘ | ✘ | ✘ |
pharmaceuticals | 5 | ✘ | ✘ | ✘ |
investors | 5 | ✘ | ✘ | ✘ |
news | 4 | ✘ | ✘ | ✘ |
media | 4 | ✘ | ✘ | ✘ |
diseases | 4 | ✘ | ✘ | ✘ |
events | 4 | ✘ | ✘ | ✘ |
pipeline | 4 | ✘ | ✘ | ✘ |
treatment | 4 | ✘ | ✘ | ✘ |
With 1.68 seconds in page load, 73 KB of page size and all other reports below, the canbridgepharma.com has a SEO score of 42 out of 100 |
Title | Home | CANbridge |
Description | Established in 2012, CANbridge is a leading China-based, global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. |
Keyword | CANbridge, CANbridge Pharmaceuticals Inc, CANbridge Pharmaceuticals |
Age | 10 Years, 258 Days |
Created | 16th-Aug-2012 |
Updated | 14th-Feb-2022 |
Expiry | 16th-Aug-2025 |
Host | Type | Ttl | Other |
---|---|---|---|
canbridgepharma.com | A | 577 | ip:42.159.132.179 |
canbridgepharma.com | NS | 3600 | target:dns21.hichina.com |
canbridgepharma.com | NS | 3600 | target:dns22.hichina.com |
canbridgepharma.com | SOA | 600 | mname:dns21.hichina.comrname:hostmaster.hichina.comserial:2022052002refresh:3600retry:1200expire:86400minimum-ttl:600 |
canbridgepharma.com | MX | 600 | pri:1target:canbridgepharma-com.mail.protection.outlook.com |
canbridgepharma.com | TXT | 600 | txt:v=spf1 include:spf.protection.outlook.com -all |
canbridgepharma.com | TXT | 600 | txt:MS=ms80392859 |
canbridgepharma.com | TXT | 600 | txt:webexdomainverification.2APK=71a4d30d-edd8-4477-a283-865f593b83f1 |
canbridgepharma.com | TXT | 600 | txt:webexdomainverification.1RLI=c6ed07a8-1647-48fc-bfe3-2d623efd8e97 |
HTTP/1.1 301 Moved Permanently Content-Length: 0 Date: Tue, 02 May 2023 07:35:08 GMT Location: https://canbridgepharma.com/ HTTP/1.1 200 OK Content-Length: 74645 Content-Type: text/html; charset=utf-8 Date: Tue, 02 May 2023 07:35:10 GMT Access-Control-Expose-Headers: Request-Context Cache-Control: private Request-Context: appId=cid-v1:0134b614-6505-4c72-9fd6-95710a1b8474 X-Frame-Options: SAMEORIGIN X-XSS-Protection: 1; mode=block X-Permitted-Cross-Domain-Policies: none X-Content-Type-Options: nosniff Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-inline' 'unsafe-eval' http://cdn.jsdelivr.net https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://maxcdn.bootstrapcdn.com https://asia.tools.euroland.com https://tools.eurolandir.com https://gamma.euroland.com https://tools.euroland.com https://www.googletagmanager.com https://www.google-analytics.com http://www.google-analytics.com; style-src 'self' 'unsafe-inline' https://maxcdn.bootstrapcdn.com https://fonts.googleapis.com https://cdnjs.cloudflare.com; frame-src 'self' https://gamma.euroland.com https://asia.tools.euroland.com http://asia.tools.euroland.com https://tools.eurolandir.com http://tools.eurolandir.com https://tools.euroland.com http://tools.euroland.com; font-src 'self' https://cdnjs.cloudflare.com https://maxcdn.bootstrapcdn.com https://fonts.gstatic.com; img-src 'self' data: https://gamma.euroland.com https://asia.tools.euroland.com http://asia.tools.euroland.com https://www.gravatar.com https://our.umbraco.org https://our.umbraco.com https://umbraco.tv https://dashboard.umbraco.org www.googletagmanager.com https://www.google-analytics.com http://www.google-analytics.com; connect-src 'self' https://our.umbraco.org https://our.umbraco.com https://www.google-analytics.com; media-src 'self' https://player.vimeo.com; Referrer-Policy: no-referrer-when-downgrade |
Domain Name: canbridgepharma.com Registry Domain ID: 1739162180_DOMAIN_COM-VRSN Registrar WHOIS Server: grs-whois.hichina.com Registrar URL: http://www.net.cn Updated Date: 2022-02-14T00:48:06Z Creation Date: 2012-08-16T06:30:41Z Registrar Registration Expiration Date: 2025-08-16T06:30:41Z Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd. Registrar IANA ID: 420 Reseller: Domain Status: ok https://icann.org/epp#ok Registrant City: Registrant State/Province: Registrant Country: Registrant Email:https://whois.aliyun.com/whois/whoisForm Registry Registrant ID: Not Available From Registry Name Server: DNS21.HICHINA.COM Name Server: DNS22.HICHINA.COM DNSSEC: unsigned Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com Registrar Abuse Contact Phone: +86.95187 URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ >>>Last update of WHOIS database: 2023-05-02T07:35:24Z |
Server IP | 42.159.132.179 |
Server Location | China |
Service Provider | Shanghai Blue Cloud Technology Co.,Ltd |
Domains (TLD) | Status |
---|---|
canbridgepharma.net | Available |
canbridgepharma.org | Already Registered |
canbridgepharma.biz | Available |
canbridgepharma.io | Already Registered |
canbridgepharma.info | Already Registered |
Domains (TLD) | Status |
---|---|
xanbridgepharma.com | Available |
sanbridgepharma.com | Available |
danbridgepharma.com | Available |
fanbridgepharma.com | Available |
vanbridgepharma.com | Available |
Cjpeter.com |
Thaioneoncuisine.com |
Parcarbreaventure.com |
Koofmetlicht.nl |
Kranemann.org |
Ainalaw.com |
Embodiedpresent.com |
Cerismas.com |
Founderbookclub.com |
Ciuuyf.com |